Neurogene (NGNE) Non Operating Investment Income (2020)
Neurogene (NGNE) posted Non Operating Investment Income of $7.8 million for Q3 2020.
Neurogene (NGNE) Non Operating Investment Income (2020) Analysis & Trends
Neurogene's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $7.8 million for Q3 2020.
- Quarterly Non Operating Investment Income changed N/A year-over-year to $7.8 million in Q3 2020, while the trailing twelve-month figure through Dec 2021 was $7.8 million (changed N/A YoY) and the FY2020 annual result came in at $7.8 million, changed N/A from the prior year.
- Non Operating Investment Income was $7.8 million for Q3 2020 at Neurogene.
- Across five years, Non Operating Investment Income topped out at $7.8 million in Q3 2020 and bottomed at $7.8 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 7.83 Mn |
| Sep 30, 2020 | 7.83 Mn |